title: Effects of iron repletion and correction of anemia on norepinephrine turnover and thyroid metabolism in iron deficiency.
abstract: The reversibility of the alterations in norepinephrine (NE) content and turnover in interscapular brown adipose tissue and heart of iron-deficient rats has not been demonstrated. We therefore examined NE metabolism in age-matched male Sprague-Dawley rats depleted of iron by dietary means and after repletion with iron dextran. Heart NE content was 58, 61, and 85% of controls at 0, 3, and 7 days after repletion, whereas interscapular brown adipose tissue-NE content was 87, 103, and 104% of controls. Fractional heart NE turnover was 225% greater in iron-deficient anemics than controls but normalized within 3 days. Interscapular brown adipose tissue NE turnover was 58%, 46%, and 20% above controls in iron-deficient rats after 0, 3, or 7 days of iron repletion. Hematocrit returned to 80% of normal in 7 days. Liver triiodothyronine production also increased to 80% of control in this period. A second experiment used isovolemic exchange transfusion to examine the influence of anemia per se on these alterations in organ NE turnover. Acute correction of anemia in iron deficiency did not alter brown fat NE turnover. Heart NE turnover was significantly lower in anemic animals regardless of iron status. Defects in heart and brown fat NE metabolism are reversible within 7 days of iron treatment as are alterations in triiodothyronine production. Anemia per se has little effect on brown fat NE metabolism but does dramatically decrease heart NE content.
authors.affiliation: Nutrition Department, Pennsylvania State University, University Park 16802.
authors.forename: J L
authors.initials: JL
authors.lastname: Beard
authors.forename: B W
authors.initials: BW
authors.lastname: Tobin
authors.forename: S M
authors.initials: SM
authors.lastname: Smith
mesh_terms: D002001:Adipose Tissue, Brown / Q000378:metabolism; D000747:Anemia, Hypochromic / Q000188:drug therapy / Q000378:metabolism*; D000818:Animals; D001835:Body Weight; D006400:Hematocrit; D007274:Injections, Intraperitoneal; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000627:therapeutic use*; D008099:Liver / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism*; D014284:Triiodothyronine / Q000096:biosynthesis
chemical_list: D014284:Triiodothyronine; D007505:Iron-Dextran Complex; D009638:Norepinephrine